Prognostic Value of Child‐Turcotte Criteria in Medically Treated Cirrhosis

Hepatology

Volumn 4, Issue 3, 1984, Pages 430-435

  Christensen, Erik ^a,b   Schlichting, Poul ^a,b   Fauerholdt, Lis ^a,b   Gluud, Christian ^a,b   Andersen, Per Kragh ^a,b   Juhl, Erik ^a,b   Poulsen, Hemming ^a,b   Tygstrup, Niels ^a,b  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b University Institute of Pathological Anatomy ^*  (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; BILIRUBIN;

ASCITES; EPIDEMIOLOGY; HUMAN; LIVER; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MORTALITY; NERVOUS SYSTEM; NEUROLOGIC DISEASE; NUTRITION; PROGNOSIS; SURVIVAL; THERAPY;

ACTUARIAL ANALYSIS; ANALYSIS OF VARIANCE; BILIRUBIN; DIET; FOLLOW-UP STUDIES; HEALTH STATUS INDICATORS; HUMANS; LIVER CIRRHOSIS; NEUROLOGIC MANIFESTATIONS; PREDNISONE; PROGNOSIS; SERUM ALBUMIN;

EID: 0021265949     PISSN: 02709139     EISSN: 15273350     Source Type: Journal    
DOI: 10.1002/hep.1840040313     Document Type: Article

References (19)

1. Surgery and portal hypertension
2. Experience with portacaval shunt for portal hypertension
3. Quantity and quality of survival after portosystemic shunts
4. Survival prediction in portacaval shunts: a computerized statistical analysis
5. Variceal hemorrhage, hepatic cirrhosis, and portacaval shunts
6. Mesocaval shunts for the control of bleeding esophageal varices
7. Ten years experience with mesocaval grafts
8. Dacron interposition shunts for portal hypertension
9. Factors influencing survival after therapeutic shunts
10. Distal splenorenal shunt vs. portal‐systemic shunt: current status of a controlled trial
11. A peek at the Child‐Turcotte classification
12. A controlled study of the prophylactic portacaval shunt
13. A controlled study of the therapeutic portacaval shunt
14. Sex, ascites and alcoholism in survival of patients with cirrhosis. Effect of prednisone
15. Aspects of the natural history of gastrointestinal bleeding in cirrhosis and the effect of prednisone
16. Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examples
17. Prognostic factors in cirrhosis identified by Cox's regression model